InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,169.76
(
0.82%
)
US TECH 100
17,553.60
(
0.77%
)
Dow Jones
38,820.82
(
0.38%
)
Brent Oil
83.42
(
0.35%
)
Bitcoin
63,429.28
(
-0.89%
)
Post# of 15274
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Vaffan-Coulo

Send PM Follow Ignore
Followers 9
Posts 2581
Boards Moderated 0
Alias Born 04/15/2012

Vaffan-Coulo

Re: None

Sunday, 04/13/2014 1:02:58 PM

Sunday, April 13, 2014 1:02:58 PM

Post# of 15274
Famous last words?

In 2007, Young Hyun Lim, CEO of GEOMC, said:

"We are confident about working with CTT to bring this patented technology to commercialization in the worldwide pain management market. Daeyang has successfully created and marketed similar products with sales exceeding 1.5 million units, valued at over $500 million."

Wow! SEVEN YEARS and FOUR CEO's later, I wonder what she has to say now.

Especially since SEC filings suggest that CTTC hasn't paid GEOMC so much as a thin dime for any of its calmare purchases!
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up